Dr. Marina Konopleva is a Professor in the Departments of Oncology and Molecular Pharmacology at the Montefiore Einstein Comprehensive Cancer Center in The Bronx, NY. She serves as Director of the Leukemia Program and Co-Director of the Translational Blood Cancer Institute at Einstein-Montefiore. She maintains a part-time appointment as Professor of Leukemia at the MD Anderson Cancer Center where she leads the Leukemia SPORE. Her laboratory research focuses on approaches to activating cell death, metabolic inhibitors, and immune-oncology in AML. She is a scholar of the Leukemia and Lymphoma Society and her research is funded by the NIH, Department of Defense, and various private foundations. Her clinical translational investigations have led to many clinical trials. Dr. Konopleva actively mentors trainees at all levels. She treats patients with hematologic malignancies with a focus on acute leukemias, including high-risk myelodysplastic syndrome, chronic myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm.